{"log_id": 7516528558973412825, "direction": 0, "words_result_num": 40, "words_result": [{"probability": {"variance": 0, "average": 0.839523, "min": 0.839523}, "location": {"width": 42, "top": 93, "height": 23, "left": 1168}, "words": "食"}, {"probability": {"variance": 0, "average": 0.998609, "min": 0.998609}, "location": {"width": 26, "top": 129, "height": 26, "left": 1173}, "words": "品"}, {"probability": {"variance": 6e-06, "average": 0.992259, "min": 0.989844}, "location": {"width": 45, "top": 200, "height": 24, "left": 315}, "words": "表1"}, {"probability": {"variance": 4.1e-05, "average": 0.996783, "min": 0.981408}, "location": {"width": 136, "top": 240, "height": 25, "left": 314}, "words": "年龄范围(岁)"}, {"probability": {"variance": 0.010323, "average": 0.967333, "min": 0.541584}, "location": {"width": 424, "top": 242, "height": 33, "left": 573}, "words": "每1000例治疗患者中自杀例数的药物一安慰剂差异"}, {"probability": {"variance": 0.000437, "average": 0.979132, "min": 0.950278}, "location": {"width": 31, "top": 283, "height": 19, "left": 315}, "words": "<18"}, {"probability": {"variance": 2.5e-05, "average": 0.996964, "min": 0.982751}, "location": {"width": 175, "top": 283, "height": 29, "left": 670}, "words": "与安慰剂相比多14例"}, {"probability": {"variance": 0.013159, "average": 0.935721, "min": 0.706432}, "location": {"width": 58, "top": 323, "height": 22, "left": 316}, "words": "18~24"}, {"probability": {"variance": 6e-06, "average": 0.997953, "min": 0.993935}, "location": {"width": 168, "top": 326, "height": 24, "left": 671}, "words": "与安慰剂相比多例"}, {"probability": {"variance": 0, "average": 0.999154, "min": 0.998851}, "location": {"width": 73, "top": 304, "height": 46, "left": 859}, "words": "药业"}, {"probability": {"variance": 6.9e-05, "average": 0.992934, "min": 0.976912}, "location": {"width": 57, "top": 362, "height": 23, "left": 312}, "words": "25~64"}, {"probability": {"variance": 0.003255, "average": 0.965749, "min": 0.864702}, "location": {"width": 170, "top": 362, "height": 30, "left": 669}, "words": "与安慰剂相比1例"}, {"probability": {"variance": 0.012911, "average": 0.915959, "min": 0.755283}, "location": {"width": 38, "top": 403, "height": 21, "left": 313}, "words": "≥65"}, {"probability": {"variance": 0.014017, "average": 0.944936, "min": 0.62352}, "location": {"width": 169, "top": 404, "height": 27, "left": 669}, "words": "与安慰剂相比少6例"}, {"probability": {"variance": 0.00136, "average": 0.990676, "min": 0.771425}, "location": {"width": 720, "top": 477, "height": 36, "left": 312}, "words": "目前尚不知道在较长期用药时(如几个月以上),自杀风险是否会增加。但是在成人"}, {"probability": {"variance": 1.4e-05, "average": 0.998056, "min": 0.984415}, "location": {"width": 764, "top": 515, "height": 36, "left": 270}, "words": "抑郁症患者中进行的安慰剂对照维持治疗临床试验数据证明,使用抗抑郁药物可以延缓抑"}, {"probability": {"variance": 4e-06, "average": 0.998522, "min": 0.99434}, "location": {"width": 102, "top": 557, "height": 23, "left": 272}, "words": "郁症的复燃"}, {"probability": {"variance": 0.000347, "average": 0.992451, "min": 0.926376}, "location": {"width": 270, "top": 596, "height": 24, "left": 290}, "words": "儿童和青少年(年龄小于18岁)"}, {"probability": {"variance": 7e-05, "average": 0.997278, "min": 0.95273}, "location": {"width": 740, "top": 632, "height": 35, "left": 288}, "words": "在儿童和青少年的重性抑郁障碍和其他精神疾病患者中,自杀意念和行为的风险增加与"}, {"probability": {"variance": 4.2e-05, "average": 0.996969, "min": 0.969168}, "location": {"width": 781, "top": 672, "height": 34, "left": 247}, "words": "抗抑郁药物的治疗相关。在本品的儿童和青少年临床试验中,与安慰剂治疗者相比,帕罗西"}, {"probability": {"variance": 0.001942, "average": 0.986216, "min": 0.72179}, "location": {"width": 782, "top": 710, "height": 36, "left": 246}, "words": "汀治疗的患者中自杀迹象(自杀企图和自杀念头)以及敌意(主要表现为攻击性、对抗行为"}, {"probability": {"variance": 0.002869, "average": 0.980441, "min": 0.772662}, "location": {"width": 759, "top": 748, "height": 37, "left": 249}, "words": "和发怒)相关的不良事件比较多见(见不良反应)。目前还缺乏对儿童和青少年的生长、成熟"}, {"probability": {"variance": 2e-06, "average": 0.998392, "min": 0.994464}, "location": {"width": 299, "top": 789, "height": 28, "left": 245}, "words": "认知和行为发育的长期安全性资料"}, {"probability": {"variance": 3e-06, "average": 0.997896, "min": 0.994037}, "location": {"width": 300, "top": 829, "height": 25, "left": 286}, "words": "成年人的临床病情恶化和自杀风险"}, {"probability": {"variance": 1e-05, "average": 0.998103, "min": 0.985287}, "location": {"width": 734, "top": 866, "height": 34, "left": 285}, "words": "年轻的成年人,尤其是患有重性抑郁障碍的年轻的成年人,在使用帕罗西汀治疗期间"}, {"probability": {"variance": 0.000131, "average": 0.997024, "min": 0.928251}, "location": {"width": 775, "top": 904, "height": 36, "left": 244}, "words": "可能增加自杀行为出现的风险。一项对患有精神疾病的成年人与安慰剂对照试验分析显示"}, {"probability": {"variance": 0.002435, "average": 0.986713, "min": 0.717717}, "location": {"width": 780, "top": 944, "height": 34, "left": 247}, "words": "与安慰剂对照,使用帕罗西汀治疗的年轻的成年人(预定义年龄范围18~24岁)自杀行为"}, {"probability": {"variance": 0.01212, "average": 0.96424, "min": 0.432986}, "location": {"width": 782, "top": 982, "height": 36, "left": 244}, "words": "几率较高(17/7762.19%]比554210.92%]),尽管这个差异没有统计学意义。在较大年龄"}, {"probability": {"variance": 0.000236, "average": 0.995601, "min": 0.899924}, "location": {"width": 783, "top": 1022, "height": 36, "left": 243}, "words": "组中(25~64岁,以及等于或大于65岁),没有观察到这样的增加。患有重性抑郁障碍的"}, {"probability": {"variance": 0.000274, "average": 0.993615, "min": 0.911345}, "location": {"width": 783, "top": 1059, "height": 36, "left": 243}, "words": "成年人(所有年龄)使用帕罗西汀治疗,与使用安慰剂对照,自杀行为的几率增加具有统计"}, {"probability": {"variance": 0.012497, "average": 0.959167, "min": 0.437762}, "location": {"width": 782, "top": 1099, "height": 34, "left": 243}, "words": "学意义(11/34550.32%比1/1978【0.05%];所有的事件为自杀企图)。然而,因帕罗西汀"}, {"probability": {"variance": 0.000425, "average": 0.992138, "min": 0.87405}, "location": {"width": 782, "top": 1136, "height": 36, "left": 243}, "words": "所致(8/11)自杀企图大多数发生在18~30岁的年轻的成年人中。这些重性抑郁障碍的数"}, {"probability": {"variance": 1.1e-05, "average": 0.998342, "min": 0.983706}, "location": {"width": 781, "top": 1176, "height": 33, "left": 242}, "words": "据表明在患有精神疾病的年轻的成年人群观察到的较高自杀几率有可能外延到24岁以上的"}, {"probability": {"variance": 0, "average": 0.999466, "min": 0.998728}, "location": {"width": 61, "top": 1216, "height": 24, "left": 243}, "words": "人群中"}, {"probability": {"variance": 0.002461, "average": 0.991054, "min": 0.689445}, "location": {"width": 743, "top": 1253, "height": 35, "left": 282}, "words": "抑郁症患者无论是否服用抗抑郁药物,都可能出现抑郁症状恶化,和/或出现自杀意念"}, {"probability": {"variance": 4.7e-05, "average": 0.996406, "min": 0.958832}, "location": {"width": 780, "top": 1293, "height": 33, "left": 242}, "words": "和自杀行为(自杀象),这种危险性持续存在,直到病情显著缓解。在恢复的早期自杀危"}, {"probability": {"variance": 2.6e-05, "average": 0.998061, "min": 0.972958}, "location": {"width": 783, "top": 1332, "height": 34, "left": 240}, "words": "险性可能升高,这是所有抗抑郁药物治疗普遍的临床经验。其他用帕罗西汀治疗的精神疾病"}, {"probability": {"variance": 1.1e-05, "average": 0.998375, "min": 0.984075}, "location": {"width": 772, "top": 1371, "height": 34, "left": 242}, "words": "也可能有自杀行为的危险性升高,并且,这些情况也可能与重性抑郁障碍合并存在。此外"}, {"probability": {"variance": 6.8e-05, "average": 0.997036, "min": 0.947348}, "location": {"width": 781, "top": 1409, "height": 34, "left": 241}, "words": "有自杀行为或自杀念头病史的患者,年轻的成年人以及开始治疗前表现出明显的自杀意念的"}, {"probability": {"variance": 0.000609, "average": 0.99276, "min": 0.849415}, "location": {"width": 780, "top": 1448, "height": 34, "left": 241}, "words": "患者出现自杀念头或自杀企图的危险性较高。整个治疗期间应当监测所有患者,注意是否出"}], "language": 3}